A subset of methylated CpG sites differentiate psoriatic from normal skin

Psoriasis is a chronic inflammatory immune-mediated disorder affecting the skin and other organs including joints. Over 1,300 transcripts are altered in psoriatic involved skin compared to normal skin. However to our knowledge global epigenetic profiling of psoriatic skin is previously unreported. H...

Full description

Bibliographic Details
Main Authors: Roberson, Elisha D.O., Liu, Ying, Ryan, Caitriona, Joyce, Cailin E., Duan, Shengui, Cao, Li, Martin, Ann, Liao, Wilson, Menter, Alan, Bowcock, Anne M.
Format: Online
Language:English
Published: 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568942/
id pubmed-3568942
recordtype oai_dc
spelling pubmed-35689422013-02-11 A subset of methylated CpG sites differentiate psoriatic from normal skin Roberson, Elisha D.O. Liu, Ying Ryan, Caitriona Joyce, Cailin E. Duan, Shengui Cao, Li Martin, Ann Liao, Wilson Menter, Alan Bowcock, Anne M. Article Psoriasis is a chronic inflammatory immune-mediated disorder affecting the skin and other organs including joints. Over 1,300 transcripts are altered in psoriatic involved skin compared to normal skin. However to our knowledge global epigenetic profiling of psoriatic skin is previously unreported. Here we describe a genome-wide study of altered CpG methylation in psoriatic skin. We determined the methylation levels at 27,578 CpG sites in skin samples from individuals with psoriasis (12 involved, 8 uninvolved) and 10 unaffected individuals. CpG methylation of involved skin differed from normal skin at 1,108 sites. Twelve mapped to the epidermal differentiation complex, upstream or within genes that are highly up-regulated in psoriasis. Hierarchical clustering of 50 of the top differentially methylated (DM) sites separated psoriatic from normal skin samples. CpG sites where methylation was correlated with gene expression are reported. Sites with inverse correlations between methylation and nearby gene expression include those of KYNU, OAS2, S100A12, and SERPINB3, whose strong transcriptional up-regulation are important discriminators of psoriasis. We observed intrinsic epigenetic differences in uninvolved skin. Pyrosequencing of bisulfite-treated DNA from skin biopsies at three DM loci confirmed earlier findings and revealed reversion of methylation levels towards the non-psoriatic state after one month of anti-TNF-α therapy. 2011-11-10 2012-03 /pmc/articles/PMC3568942/ /pubmed/22071477 http://dx.doi.org/10.1038/jid.2011.348 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Roberson, Elisha D.O.
Liu, Ying
Ryan, Caitriona
Joyce, Cailin E.
Duan, Shengui
Cao, Li
Martin, Ann
Liao, Wilson
Menter, Alan
Bowcock, Anne M.
spellingShingle Roberson, Elisha D.O.
Liu, Ying
Ryan, Caitriona
Joyce, Cailin E.
Duan, Shengui
Cao, Li
Martin, Ann
Liao, Wilson
Menter, Alan
Bowcock, Anne M.
A subset of methylated CpG sites differentiate psoriatic from normal skin
author_facet Roberson, Elisha D.O.
Liu, Ying
Ryan, Caitriona
Joyce, Cailin E.
Duan, Shengui
Cao, Li
Martin, Ann
Liao, Wilson
Menter, Alan
Bowcock, Anne M.
author_sort Roberson, Elisha D.O.
title A subset of methylated CpG sites differentiate psoriatic from normal skin
title_short A subset of methylated CpG sites differentiate psoriatic from normal skin
title_full A subset of methylated CpG sites differentiate psoriatic from normal skin
title_fullStr A subset of methylated CpG sites differentiate psoriatic from normal skin
title_full_unstemmed A subset of methylated CpG sites differentiate psoriatic from normal skin
title_sort subset of methylated cpg sites differentiate psoriatic from normal skin
description Psoriasis is a chronic inflammatory immune-mediated disorder affecting the skin and other organs including joints. Over 1,300 transcripts are altered in psoriatic involved skin compared to normal skin. However to our knowledge global epigenetic profiling of psoriatic skin is previously unreported. Here we describe a genome-wide study of altered CpG methylation in psoriatic skin. We determined the methylation levels at 27,578 CpG sites in skin samples from individuals with psoriasis (12 involved, 8 uninvolved) and 10 unaffected individuals. CpG methylation of involved skin differed from normal skin at 1,108 sites. Twelve mapped to the epidermal differentiation complex, upstream or within genes that are highly up-regulated in psoriasis. Hierarchical clustering of 50 of the top differentially methylated (DM) sites separated psoriatic from normal skin samples. CpG sites where methylation was correlated with gene expression are reported. Sites with inverse correlations between methylation and nearby gene expression include those of KYNU, OAS2, S100A12, and SERPINB3, whose strong transcriptional up-regulation are important discriminators of psoriasis. We observed intrinsic epigenetic differences in uninvolved skin. Pyrosequencing of bisulfite-treated DNA from skin biopsies at three DM loci confirmed earlier findings and revealed reversion of methylation levels towards the non-psoriatic state after one month of anti-TNF-α therapy.
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568942/
_version_ 1611953763586670592